Effect of Prior Antibiotic Use on Culture Results in People with Diabetes and Foot Osteomyelitis

Author:

Gramberg Meryl Cinzía Tila Tamara1234,Van Hattem Jarne Marijn5,Dijkstra Jacob Albert6,Dros Emma6,Nieuwdorp Max47,Sabelis Louise Willy Elizabeth348,Peters Edgar Josephus Gerardus124ORCID

Affiliation:

1. Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Section of Infectious Diseases, De Boelelaan 1117, NL-1081HV Amsterdam, The Netherlands

2. Amsterdam Institute for Infection and Immunity and Amsterdam Movement Sciences, P.O. Box 22660, NL-1100DD Amsterdam, The Netherlands

3. Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Rehabilitation Medicine, De Boelelaan 1117, NL-1081HV Amsterdam, The Netherlands

4. Amsterdam UMC Center for Diabetic Foot Complications (ACDC), P.O. Box 22660, NL-1100DD Amsterdam, The Netherlands

5. Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Microbiology and Infection Prevention, Meibergdreef 9, NL-1100DD Amsterdam, The Netherlands

6. Department of Pharmacy and Clinical Pharmacology, Amsterdam University Medical Center, NL-1081HV Amsterdam, The Netherlands

7. Amsterdam UMC, Location University of Amsterdam, Department of Experimental Vascular Medicine, Meibergdreef 9, NL-1100DD Amsterdam, The Netherlands

8. Amsterdam Movement Sciences, P.O. Box 22660, NL-1100DD Amsterdam, The Netherlands

Abstract

Background: Antibiotic use prior to biopsy acquisition in people with diabetes and osteomyelitis of the foot (DFO) might influence bacterial yield in cultures or induce bacterial resistance. Obtaining reliable culture results is pivotal to guide antibiotics for conservative treatment of DFO. Methods: We prospectively analysed cultures of ulcer bed and percutaneous bone biopsies of people with DFO and investigated if antibiotics administered prior to (<2 months up to 7 days) biopsy acquisition led to more negative cultures or increased resistance in virulent bacteria. We calculated relative risks (RR) and 95% confidence intervals (CIs). We stratified analyses according to biopsy type (ulcer bed or bone). Results: We analysed bone and ulcer bed biopsies of 64 people, of whom 29 received prior antibiotics, and found that prior antibiotics did not lead to a higher risk of at least one negative culture (RR 1.3, (CI 0.8–2.0), nor did prior treatment increase the risk of a specific type of negative culture (RR for bone cultures 1.15, (CI 0.75–1.7), RR for ulcer bed cultures 0.92 (CI 0.33–2.6)) or both cultures (RR 1.3 (CI 0.35–4.7), and neither did it increase the risk of antibiotic resistance in the combined bacterial results of ulcer bed and bone cultures (RR 0.64, (CI 0.23–1.8)). Conclusions: Antibiotics administered up to 7 days before obtaining biopsies in people with DFO do not influence culture yield regardless of biopsy type, nor are they associated with more antibiotic resistance.

Funder

Dutch Diabetes Research Foundation

ZonMW-VICI

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3